| 引用本文:柳莺莺，周亚东.美国中医药立法现状及我国应对策略[J].世界中医药,2023,(09):. |
|
| 美国中医药立法现状及我国应对策略 |
| Current Legislative Status of Traditional Chinese Medicine in the US and the Countermeasures of China |
| 投稿时间：2021-09-12 |
| DOI：10.3969/j.issn.1673-7202.2023.09.026 |
| 中文关键词: 美国 中医药 针灸 中草药 医保 立法现状 困境 对策 |
| English Keywords:the US Traditional Chinese medicine Acupuncture and moxibustion Chinese herbal medicine Medical insurance Current legislative status Dilemma Countermeasures |
| 基金项目:2020安徽省哲学社会科学规划专项课题（AHSKXZX2020D06）；2020年安徽省卫生健康软科学研究重点项目（2020WR02002） |
|
| 摘要点击次数: 550 |
| 全文下载次数: 0 |
| 中文摘要: |
| 美国中医药立法情况影响中医药在美国的整体发展，由于两国在国情、法律、文化、语言等方面的差异，中医药在美国立法状况不容乐观且发展缓慢。通过梳理中医药在美国立法现状，收集并整理大量第一手数据信息，结合美国食品和药品相关法律法规中与中药相关的内容，分析美国中医药立法取得的进展以及存在的问题，针对问题提出我国推动中医药走向国际的对策。 |
| English Summary: |
| The legislative situation of traditional Chinese medicine(TCM) in the US affects the overall development of TCM in the US.However，due to the differences in national conditions，laws，culture，and language between China and the US，the legislation of TCM in the US is not optimistic and remains slow.By sorting out the current status of the legislation of TCM in the US，collecting and collating a large amount of first-hand data as well as information，and combining the laws and regulations related to TCM mentioned in the Food and Drug Administration of the US，this paper analyzed the current progress and issues in the legislation of TCM in the US and proposed countermeasures for China in the promotion of TCM to the international arena in response to these issues. |
| 查看全文 查看/发表评论 下载PDF阅读器 |
